- Featured Modules
- Most Popular
- Use Cases
When it comes to certain types of products for sale, the US government has a hand in regulating those products.
This extends past just how they’re sold and often into the realms of how they’re manufactured as well. A good example of this is how the US Food and Drug Administration requires drug manufacturers to follow strict requirements for all of their products.
The FDA does this by imposing GMP pharmaceutical requirements on drug manufacturers. But why does the FDA make use of GMP? What form do these requirements take, and how does the government watchdog have the authority to do this? Answers to all these questions and more are below.
The FDA’s GMP pharmaceutical requirements aren’t just arbitrary; there’s a reason they’re set in place. The main goal of these requirements is to ensure that the manufacturers making these products are offering drugs and supplements that are safe for people to take. The FDA is fully invested in preventing any commercial drug products in the US from being made available without first meeting minimum standards in how those pharmaceuticals are manufactured, processed, and packed. Meanwhile, the facilities these drugs are made, and the quality control measures the manufacturer uses, are also subject to regulation.
The FDA gets this authority from being a division of the US Department of Health and Human Services. The US Code of Federal Regulations, specifically Title 21 of that code, is the relevant federal law that makes this a reality.
Any company regulated by the FDA that doesn’t meet GMP pharmaceutical requirements can be subject to sometimes harsh penalties. Thanks to the Food, Drug, and Cosmetic Act, which has been in existence since 1938, the FDA can issue warnings to manufacturers in violation, seize unsafe products before they can be put on sale, and even file injunctions against manufacturers to prevent them from certain activity. Finally, manufacturers can even be brought up on criminal charges.
In particularly dire circumstances, pharmaceutical manufacturers can be fined half a million dollars for every GMP pharmaceutical requirement that they violate. These consequences are the same whether the violation was a misdemeanor that ended in death or a felony. Additionally, executives and employees of a manufacturer can even face prison time. Those found guilty of a misdemeanor can be placed in jail for up to a year, while felonies carry a maximum sentence of three years.
The FDA’s GMP pharmaceutical requirements were specifically put in place to protect public health. Without the ability to hold drug manufacturers accountable and to require them to follow GMP regulations to the letter, the FDA would not have any way to ensure that only the safest and highest-quality products are made available to people looking for pharmaceuticals in the US.
Healthcare utilization management, another critical aspect of healthcare regulation, works in conjunction with these requirements to optimize the use of healthcare resources, including pharmaceuticals. Utilization management strategies aim to ensure that medications are prescribed and utilized appropriately, based on evidence-based guidelines, clinical necessity, and cost-effectiveness. These strategies help prevent over-utilization, misuse, and unnecessary healthcare expenses, all while improving patient outcomes and enhancing the quality of care.
By implementing utilization management protocols, healthcare organizations and insurers can closely monitor medication usage, review appropriateness, and prevent potential issues such as medication interactions or excessive dosages. Collaboration between healthcare providers, insurers, and regulatory bodies is vital in executing utilization management programs effectively. This collective effort not only promotes patient safety but also contributes to controlling healthcare costs and maintaining the integrity of the healthcare system.
Explore more workplace safety resources from the EHS Insight Blog.View All Posts